Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marcelo F. Di Carli, M.D.

Co-Author

Back to Details
This page shows the publications co-authored by Marcelo Di Carli and Sharmila Dorbala.
Marcelo Di Carli
Connection Strength
19.939
Sharmila Dorbala
  1. Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride-Based SPECT/CT. J Nucl Med. 2021 May 10; 62(5):716-722.
    View in: PubMed
    Score: 0.950
  2. Approaches to reducing radiation dose from radionuclide myocardial perfusion imaging. J Nucl Med. 2015 Apr; 56(4):592-9.
    View in: PubMed
    Score: 0.650
  3. Cardiac PET perfusion: prognosis, risk stratification, and clinical management. Semin Nucl Med. 2014 Sep; 44(5):344-57.
    View in: PubMed
    Score: 0.627
  4. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging. 2009 Jul; 2(7):846-54.
    View in: PubMed
    Score: 0.438
  5. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. J Nucl Med. 2007 Mar; 48(3):349-58.
    View in: PubMed
    Score: 0.372
  6. Cardiac PET-CT. J Thorac Imaging. 2007 Feb; 22(1):101-6.
    View in: PubMed
    Score: 0.370
  7. Prognostic value of SPECT myocardial perfusion imaging in patients with elevated cardiac troponin I levels and atypical clinical presentation. J Nucl Cardiol. 2007 Jan; 14(1):53-8.
    View in: PubMed
    Score: 0.368
  8. Myocardial perfusion imaging and multidetector computed tomographic coronary angiography: appropriate for all patients with suspected coronary artery disease? J Am Coll Cardiol. 2006 Dec 19; 48(12):2515-7.
    View in: PubMed
    Score: 0.366
  9. Integrated PET/CT for cardiac imaging. Q J Nucl Med Mol Imaging. 2006 Mar; 50(1):44-52.
    View in: PubMed
    Score: 0.347
  10. Effect of body mass index on left ventricular cavity size and ejection fraction. Am J Cardiol. 2006 Mar 01; 97(5):725-9.
    View in: PubMed
    Score: 0.344
  11. Cardiology patient page. Exercise testing and nuclear scanning. Circulation. 2003 Apr 29; 107(16):e100-2.
    View in: PubMed
    Score: 0.285
  12. Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders. JACC Cardiovasc Imaging. 2021 Mar 10.
    View in: PubMed
    Score: 0.246
  13. Cardiopulmonary transit time: A novel PET imaging biomarker of in vivo physiology for risk stratification of heart transplant recipients. J Nucl Cardiol. 2021 Jan 04.
    View in: PubMed
    Score: 0.243
  14. Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2020 Sep 11.
    View in: PubMed
    Score: 0.238
  15. Coronary vasomotor dysfunction in cancer survivors treated with thoracic irradiation. J Nucl Cardiol. 2020 Jul 20.
    View in: PubMed
    Score: 0.235
  16. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J. 2020 07 01; 41(25):2366-2375.
    View in: PubMed
    Score: 0.235
  17. Coronary microvascular dysfunction in patients with psoriasis. J Nucl Cardiol. 2020 May 17.
    View in: PubMed
    Score: 0.233
  18. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease? JACC Cardiovasc Imaging. 2020 06; 13(6):1325-1336.
    View in: PubMed
    Score: 0.232
  19. Quantitative [18F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosis. Eur J Nucl Med Mol Imaging. 2020 07; 47(8):1998-2009.
    View in: PubMed
    Score: 0.226
  20. Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment. Circulation. 2020 01 07; 141(1):21-33.
    View in: PubMed
    Score: 0.225
  21. Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using 18F-Florbetapir PET/CT. J Nucl Cardiol. 2019 Nov 22.
    View in: PubMed
    Score: 0.225
  22. Stress Myocardial Perfusion PET Provides Incremental Risk Prediction in Patients with and Patients without Diabetes. Radiol Cardiothorac Imaging. 2019 Jun; 1(2):e180018.
    View in: PubMed
    Score: 0.219
  23. Imaging of cardiac amyloidosis: Will this become a unique application for dual-isotope imaging? J Nucl Cardiol. 2020 02; 27(1):38-40.
    View in: PubMed
    Score: 0.218
  24. Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study. J Nucl Cardiol. 2019 Jun 13.
    View in: PubMed
    Score: 0.218
  25. Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2019 06; 12(6):e008975.
    View in: PubMed
    Score: 0.218
  26. Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States. Circ Heart Fail. 2019 06; 12(6):e005407.
    View in: PubMed
    Score: 0.218
  27. Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis. J Nucl Cardiol. 2021 Apr; 28(2):579-588.
    View in: PubMed
    Score: 0.216
  28. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body 18F-Florbetapir PET/CT. J Nucl Med. 2019 09; 60(9):1234-1239.
    View in: PubMed
    Score: 0.215
  29. Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT. Radiology. 2019 05; 291(2):330-337.
    View in: PubMed
    Score: 0.214
  30. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nucl Cardiol. 2019 02; 26(1):158-173.
    View in: PubMed
    Score: 0.211
  31. Correction to: Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol. 2018 Dec; 25(6):2189-2190.
    View in: PubMed
    Score: 0.210
  32. Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis. JAMA Cardiol. 2018 09 01; 3(9):865-870.
    View in: PubMed
    Score: 0.207
  33. Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits. JACC Cardiovasc Imaging. 2019 07; 12(7 Pt 1):1165-1173.
    View in: PubMed
    Score: 0.206
  34. Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction. JACC Clin Electrophysiol. 2018 09; 4(9):1200-1210.
    View in: PubMed
    Score: 0.205
  35. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018 03 07; 39(10):840-849.
    View in: PubMed
    Score: 0.200
  36. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy. Eur Heart J. 2018 01 21; 39(4):316-323.
    View in: PubMed
    Score: 0.198
  37. Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases. J Am Coll Cardiol. 2017 12 05; 70(22):2835-2837.
    View in: PubMed
    Score: 0.196
  38. Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int. 2018 02; 93(2):501-509.
    View in: PubMed
    Score: 0.194
  39. Integrated Noninvasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients With Stable Coronary Artery Disease. Circulation. 2017 Dec 12; 136(24):2325-2336.
    View in: PubMed
    Score: 0.193
  40. Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies. Heart Fail Rev. 2017 07; 22(4):455-464.
    View in: PubMed
    Score: 0.191
  41. Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function. J Am Heart Assoc. 2017 May 04; 6(5).
    View in: PubMed
    Score: 0.188
  42. Editor's Note. Circ Cardiovasc Imaging. 2017 03; 10(3).
    View in: PubMed
    Score: 0.186
  43. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease. Circulation. 2017 02 07; 135(6):566-577.
    View in: PubMed
    Score: 0.182
  44. SU-F-I-31: Reproducibility of An Automatic Exposure Control Technique in the Low-Dose CT Scan of Cardiac PET/CT Exams. Med Phys. 2016 Jun; 43(6):3393-3394.
    View in: PubMed
    Score: 0.177
  45. Utility of multimodality imaging in myopericarditis with aortitis. J Nucl Cardiol. 2017 06; 24(3):1103-1106.
    View in: PubMed
    Score: 0.176
  46. Utility of multimodality imaging in suspected prosthetic valve endocarditis. J Nucl Cardiol. 2016 Apr; 23(2):316-20.
    View in: PubMed
    Score: 0.171
  47. Prognostic Value of Coronary Flow Reserve in Patients with Dialysis-Dependent ESRD. J Am Soc Nephrol. 2016 06; 27(6):1823-9.
    View in: PubMed
    Score: 0.169
  48. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study. Circ Cardiovasc Imaging. 2015 Aug; 8(8).
    View in: PubMed
    Score: 0.167
  49. Utility of multimodality imaging in diagnosis and follow-up of aortitis. J Nucl Cardiol. 2016 Jun; 23(3):590-5.
    View in: PubMed
    Score: 0.166
  50. Clinical applications of radionuclide imaging in the evaluation and management of patients with congenital heart disease. J Nucl Cardiol. 2016 Feb; 23(1):45-63.
    View in: PubMed
    Score: 0.166
  51. Left atrial enlargement increases the risk of major adverse cardiac events independent of coronary vasodilator capacity. Eur J Nucl Med Mol Imaging. 2015 Sep; 42(10):1551-61.
    View in: PubMed
    Score: 0.165
  52. Response to letter regarding article, "effects of sex on coronary microvascular dysfunction and cardiac outcomes". Circulation. 2015 Mar 17; 131(11):e376.
    View in: PubMed
    Score: 0.163
  53. Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. Eur Heart J Cardiovasc Imaging. 2015 Aug; 16(8):900-9.
    View in: PubMed
    Score: 0.162
  54. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. Circulation. 2015 Feb 10; 131(6):528-35.
    View in: PubMed
    Score: 0.159
  55. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015 Jan 06; 131(1):19-27.
    View in: PubMed
    Score: 0.159
  56. Reply: (18)F-FDG imaging in patients with "suspected," but not "proven," sarcoidosis. J Am Coll Cardiol. 2014 Aug 12; 64(6):631.
    View in: PubMed
    Score: 0.156
  57. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail. 2014 Aug; 2(4):358-67.
    View in: PubMed
    Score: 0.155
  58. Imaging cardiac amyloidosis: a pilot study using ¹8F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging. 2014 Sep; 41(9):1652-62.
    View in: PubMed
    Score: 0.154
  59. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014 Jun 17; 129(24):2518-27.
    View in: PubMed
    Score: 0.153
  60. Reply: Cardiac positron emission tomography as a prognostic indicator of cardiac sarcoidosis. J Am Coll Cardiol. 2014 Jun 17; 63(23):2590.
    View in: PubMed
    Score: 0.152
  61. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med. 2014 Feb; 55(2):248-55.
    View in: PubMed
    Score: 0.150
  62. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014 Feb 04; 63(4):329-36.
    View in: PubMed
    Score: 0.147
  63. Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging. J Nucl Med. 2013 Oct; 54(10):1748-54.
    View in: PubMed
    Score: 0.146
  64. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013 Aug; 54(8):1485-507.
    View in: PubMed
    Score: 0.144
  65. Value of reserve pulse pressure in improving the risk stratification of patients with normal myocardial perfusion imaging. Eur Heart J. 2013 Jul; 34(27):2074-81a.
    View in: PubMed
    Score: 0.142
  66. Prognostic interplay of coronary artery calcification and underlying vascular dysfunction in patients with suspected coronary artery disease. J Am Coll Cardiol. 2013 May 21; 61(20):2098-106.
    View in: PubMed
    Score: 0.142
  67. Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry. J Am Coll Cardiol. 2013 Jan 15; 61(2):176-84.
    View in: PubMed
    Score: 0.139
  68. Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. JACC Cardiovasc Imaging. 2012 Oct; 5(10):1025-34.
    View in: PubMed
    Score: 0.137
  69. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012 Oct 09; 126(15):1858-68.
    View in: PubMed
    Score: 0.136
  70. Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test. J Nucl Cardiol. 2012 Oct; 19(5):970-8.
    View in: PubMed
    Score: 0.133
  71. Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion. J Am Coll Cardiol. 2011 Oct 18; 58(17):1807-16.
    View in: PubMed
    Score: 0.128
  72. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011 Nov 15; 124(20):2215-24.
    View in: PubMed
    Score: 0.128
  73. Coronary circulatory function in patients with the metabolic syndrome. J Nucl Med. 2011 Sep; 52(9):1369-77.
    View in: PubMed
    Score: 0.127
  74. Assessment of myocardial perfusion and function with PET and PET/CT. J Nucl Cardiol. 2010 Jun; 17(3):498-513.
    View in: PubMed
    Score: 0.117
  75. Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction. Circ Cardiovasc Imaging. 2009 Nov; 2(6):429-36.
    View in: PubMed
    Score: 0.111
  76. Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: comparison with (13)N-ammonia PET. J Nucl Med. 2009 Jul; 50(7):1062-71.
    View in: PubMed
    Score: 0.109
  77. Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging. Eur J Nucl Med Mol Imaging. 2009 Oct; 36(10):1603-10.
    View in: PubMed
    Score: 0.108
  78. Multimodality imaging of an unusual case of cardiac paraganglioma. J Nucl Cardiol. 2009 Jul-Aug; 16(4):644-7.
    View in: PubMed
    Score: 0.107
  79. Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging. 2008 Sep; 35(9):1593-601.
    View in: PubMed
    Score: 0.101
  80. Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study. Circulation. 2008 Apr 01; 117(13):1693-700.
    View in: PubMed
    Score: 0.100
  81. Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol. 2007 Nov-Dec; 14(6):799-809.
    View in: PubMed
    Score: 0.097
  82. Clinical myocardial perfusion PET/CT. J Nucl Med. 2007 May; 48(5):783-93.
    View in: PubMed
    Score: 0.094
  83. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol. 2007 Mar 13; 49(10):1052-8.
    View in: PubMed
    Score: 0.093
  84. Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease. J Nucl Cardiol. 2006 Nov; 13(6):761-7.
    View in: PubMed
    Score: 0.091
  85. Occupational radiation dose associated with Rb-82 myocardial perfusion positron emission tomography imaging. J Nucl Cardiol. 2006 May-Jun; 13(3):378-84.
    View in: PubMed
    Score: 0.088
  86. Integrated cardiac PET-CT for the diagnosis and management of CAD. J Nucl Cardiol. 2006 Mar-Apr; 13(2):139-44.
    View in: PubMed
    Score: 0.087
  87. Quantitative relation of ST-segment depression during exercise to the magnitude of myocardial ischemia as assessed by single-photon emission computed tomographic myocardial perfusion imaging. Am J Cardiol. 2004 Sep 15; 94(6):703-8.
    View in: PubMed
    Score: 0.079
  88. Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure. Curr Cardiol Rep. 2003 Jan; 5(1):32-9.
    View in: PubMed
    Score: 0.070
  89. Prognostically safe stress-only single-photon emission computed tomography myocardial perfusion imaging guided by machine learning: report from REFINE SPECT. Eur Heart J Cardiovasc Imaging. 2021 May 10; 22(6):705-714.
    View in: PubMed
    Score: 0.062
  90. Quantitation of Post-Stress Change in Ventricular Morphology Improves Risk Stratification. J Nucl Med. 2021 Mar 12.
    View in: PubMed
    Score: 0.062
  91. Automated quantitative analysis of CZT SPECT stratifies cardiovascular risk in the obese population: Analysis of the REFINE SPECT registry. J Nucl Cardiol. 2020 Sep 14.
    View in: PubMed
    Score: 0.060
  92. Impact of Early Revascularization on Major Adverse Cardiovascular Events in Relation to Automatically Quantified Ischemia. JACC Cardiovasc Imaging. 2021 Mar; 14(3):644-653.
    View in: PubMed
    Score: 0.059
  93. Appropriate Use Criteria for PET Myocardial Perfusion Imaging. J Nucl Med. 2020 08; 61(8):1221-1265.
    View in: PubMed
    Score: 0.059
  94. A Clinical Tool to Identify Candidates for Stress-First Myocardial Perfusion Imaging. JACC Cardiovasc Imaging. 2020 10; 13(10):2193-2202.
    View in: PubMed
    Score: 0.059
  95. Machine learning predicts per-vessel early coronary revascularization after fast myocardial perfusion SPECT: results from multicentre REFINE SPECT registry. Eur Heart J Cardiovasc Imaging. 2020 05 01; 21(5):549-559.
    View in: PubMed
    Score: 0.058
  96. Myocardial Ischemic Burden and Differences in Prognosis Among Patients With and Without Diabetes: Results From the Multicenter International REFINE SPECT Registry. Diabetes Care. 2020 02; 43(2):453-459.
    View in: PubMed
    Score: 0.056
  97. Appropriateness of inpatient stress testing: Implications for development of clinical decision support mechanisms and future criteria. J Nucl Cardiol. 2019 Nov 18.
    View in: PubMed
    Score: 0.056
  98. 5-Year Prognostic Value of Quantitative Versus Visual MPI in Subtle Perfusion Defects: Results From REFINE SPECT. JACC Cardiovasc Imaging. 2020 03; 13(3):774-785.
    View in: PubMed
    Score: 0.055
  99. Upper reference limits of transient ischemic dilation ratio for different protocols on new-generation cadmium zinc telluride cameras: A report from REFINE SPECT registry. J Nucl Cardiol. 2020 08; 27(4):1180-1189.
    View in: PubMed
    Score: 0.054
  100. Assessment of Cardiac Masses by Cardiac Magnetic Resonance Imaging: Histological Correlation and Clinical Outcomes. J Am Heart Assoc. 2019 01 08; 8(1):e007829.
    View in: PubMed
    Score: 0.053
  101. Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter Study. J Nucl Med. 2019 05; 60(5):664-670.
    View in: PubMed
    Score: 0.052
  102. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients. J Am Coll Cardiol. 2018 08 14; 72(7):707-717.
    View in: PubMed
    Score: 0.051
  103. Erratum to: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 Aug; 25(4):1147.
    View in: PubMed
    Score: 0.051
  104. Is There an Age When Myocardial Perfusion Imaging May No Longer Be Prognostically Useful? Circ Cardiovasc Imaging. 2018 07; 11(7):e007322.
    View in: PubMed
    Score: 0.051
  105. Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT). J Nucl Cardiol. 2020 06; 27(3):1010-1021.
    View in: PubMed
    Score: 0.051
  106. Deep Learning for Prediction of Obstructive Disease From Fast Myocardial Perfusion SPECT: A Multicenter Study. JACC Cardiovasc Imaging. 2018 11; 11(11):1654-1663.
    View in: PubMed
    Score: 0.050
  107. Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Cardiol. 2018 Feb; 25(1):269-297.
    View in: PubMed
    Score: 0.050
  108. Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis. Circ Cardiovasc Imaging. 2018 01; 11(1):e007030.
    View in: PubMed
    Score: 0.049
  109. Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC. J Nucl Med. 2018 02; 59(2):273-293.
    View in: PubMed
    Score: 0.049
  110. Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease. Eur J Nucl Med Mol Imaging. 2018 04; 45(4):538-548.
    View in: PubMed
    Score: 0.049
  111. Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017 10; 24(5):1741-1758.
    View in: PubMed
    Score: 0.048
  112. Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. J Nucl Med. 2017 08; 58(8):1341-1353.
    View in: PubMed
    Score: 0.048
  113. Prognostic significance of blood pressure response during vasodilator stress Rb-82 positron emission tomography myocardial perfusion imaging. J Nucl Cardiol. 2017 12; 24(6):1966-1975.
    View in: PubMed
    Score: 0.045
  114. Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. 2018 08; 25(4):1136-1146.
    View in: PubMed
    Score: 0.045
  115. Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry. Eur Heart J Cardiovasc Imaging. 2015 Dec; 16(12):1338-46.
    View in: PubMed
    Score: 0.041
  116. Comparison of the use of downstream tests after exercise treadmill testing by cardiologists versus noncardiologists. Am J Cardiol. 2014 Jul 15; 114(2):305-11.
    View in: PubMed
    Score: 0.038
  117. Prognostic value of PET myocardial perfusion imaging in obese patients. JACC Cardiovasc Imaging. 2014 Mar; 7(3):278-87.
    View in: PubMed
    Score: 0.038
  118. Yield of downstream tests after exercise treadmill testing: a prospective cohort study. J Am Coll Cardiol. 2014 Apr 08; 63(13):1264-1274.
    View in: PubMed
    Score: 0.038
  119. Prognostic significance of impaired chronotropic response to pharmacologic stress Rb-82 PET. J Nucl Cardiol. 2014 Apr; 21(2):233-44.
    View in: PubMed
    Score: 0.038
  120. Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients. Eur Heart J Cardiovasc Imaging. 2014 Jul; 15(7):787-92.
    View in: PubMed
    Score: 0.038
  121. Reduction in ¹8F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014 Feb; 21(1):166-74.
    View in: PubMed
    Score: 0.037
  122. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol. 2013 Oct 29; 62(18):1639-1653.
    View in: PubMed
    Score: 0.037
  123. Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry. J Am Coll Cardiol. 2013 Nov 12; 62(20):1866-76.
    View in: PubMed
    Score: 0.036
  124. Use of multimodality imaging to diagnose cardiac sarcoidosis as well as identify recurrence following heart transplantation. J Nucl Cardiol. 2013 Apr; 20(2):310-2.
    View in: PubMed
    Score: 0.035
  125. Use of high-risk features from exercise treadmill testing to identify obstructive left main disease with normal myocardial perfusion imaging. J Nucl Cardiol. 2012 Aug; 19(4):814-7.
    View in: PubMed
    Score: 0.034
  126. Correlative imaging of spontaneous coronary artery dissection. J Nucl Cardiol. 2012 Jun; 19(3):625-9.
    View in: PubMed
    Score: 0.034
  127. Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol. 2012 Jan 31; 59(5):462-74.
    View in: PubMed
    Score: 0.033
  128. Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET. J Nucl Cardiol. 2010 Apr; 17(2):328-32.
    View in: PubMed
    Score: 0.029
  129. Association of electrocardiographic morphology of exercise-induced ventricular arrhythmia with mortality. Ann Intern Med. 2008 Oct 07; 149(7):451-60, W82.
    View in: PubMed
    Score: 0.026
  130. Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol. 2007 Feb 27; 49(8):855-62.
    View in: PubMed
    Score: 0.023
  131. Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging. J Am Coll Cardiol. 2005 Feb 15; 45(4):553-8.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.